| Leistner, Hermann (Stratec Biomedical Systems –201103 CEO + Founder retired 3/11) |
Chief Executive Officer (CEO) |
Stratec (Group) |
Germany |
| Leitner, Michael (Public Health PR 201009 Managing Director) |
Managing Director |
Public Health PR-Projektgesellschaft mbH |
Austria |
| Leitzke, Achim (Macherey-Nagel 201902 General Manager Sales + Marketing) |
Sales Manager / Marketing Manager |
Macherey-Nagel GmbH & Co KG |
Germany |
| Lelieveld, Paul (Stichting Participatie Atriva 201702 Director + Meneldor 201806 Co-Founder) |
Investment Manager |
Stichting Participatie Atriva (Foundation Participation Atriva) |
Netherlands |
| Lelouche, Erick (Boehringer 201804 President of Boehringer Ingelheim Animal Health France) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
France |
| Lemaître, Marc (Solvay 201108 Executive Board Director) |
Board member, executive |
Solvay (Group) |
Germany |
| Lemarie, Cedric (Agilent 200809) |
n. a. |
Agilent (Group) |
Germany |
| Lemere, Cynthia (Brigham & Women’s Hospital + Harvard Medical School 201011 Assoc Prof) |
Professor |
Partners HealthCare System (Group) |
United States (USA) |
| Lemke, Andreas (Mediaire 202012 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Mediaire GmbH |
Germany |
| Lemmen, Christian (BioSolveIT GmbH 201110 Managing Director) |
Managing Director |
BioSolveIT GmbH |
Germany |
| Lemmens, Katrien (SGS 201611– Medical Director Early Phase Clinical Trials at SGS Clinical Research) |
Managing Director |
SGS (Group) |
Belgium |
| Lemus, Dave (Proteros 201712– COO + CFO before Medigene + Sigma-Tau Pharmaceuticals + MorphoSys) |
Chief Operating Officer (COO) |
Proteros (Group) |
Germany |
| Lenarz, Thomas (MHH 201009 Professor + Clinical Director) |
Professor |
MHH (Hanover Medical School / Medizinische Hochschule Hannover) |
Germany |
| Lendi, Pietro (Bruker 201104 VP RnD Bruker BioSpin CH) |
Research & Development Manager |
Bruker (Group) |
Switzerland |
| Lengauer, Christoph (Third Rock Ventures 201807 Venture Partner + Germany (govt) 201601 CEO of GALS) |
business program (governmental) |
Third Rock Ventures LLC |
United States (USA) |
| Lengauer, Th. |
n. a. |
Fraunhofer (Group) |
Germany |
| Lenggenhager, René (Bruker Corp 201511– President of BioSpin Group before Mettler Toledo since 2000 before Siemens) |
President/Director/Head Business Group/Unit/Division |
Bruker (Group) |
Germany |
| Lenk, Norbert (Nano Analytik GmbH 201004– Managing Director) |
Managing Director |
Nano Analytik GmbH |
Germany |
| Lenke, Rolf (Dechema) |
n. a. |
DECHEMA Gesellschaft für Chemische Technik und Biotechnologie e. V. |
Germany |
| Lennon, Dave (Novartis/AveXis 201904 President) |
President/Director/Head Business Group/Unit/Division |
Novartis (Group) |
United States (USA) |
| Lensky, Stephan (EpimAb Biotherapeutics 201610 COO/CBO) |
Chief Operating Officer (COO) |
EpimAb Biotherapeutics (Group) |
China |
| Lenz, Christof (Hemovent GmbH 201602 Managing Director (CEO) + Co-Founder) |
Managing Director |
Hemovent GmbH |
Germany |
| Lenz, Ruxandra (SphingoTec 202111 Senior Manager Marketing + Communications before Centogene) |
Public Relations Manager / Investor Relations Manager |
SphingoTec (Group) |
Germany |
| Leo, Chandra P. (HBM 201810) |
Investment Manager |
HBM (Group) |
Switzerland |
| Leo, Giovanni (EFI Lake Geneva Ventures I 202306 Partner + EBAMed 202306 Co-Founder + Chair) |
Partner (venture partner) |
|
|
| León, Lucas (Akvolution GmbH 201608 CFO + Founder) |
Chief Financial Officer (CFO) |
Akvolution GmbH (Akvola Technologies) |
Germany |
| Leonard, John M. (Intellia Therapeutics 201801– CEO joined 2014 before 22 years at AbbVie + Abbott) |
Chief Executive Officer (CEO) |
Intellia Therapeutics Inc. (Nasdaq: NTLA) |
United States (USA) |
| Leonard, Keith (Kythera 201101 CEO + Co-founder before SVP + General Manager Amgen Europe) |
Chief Executive Officer (CEO) |
Allergan (Group) |
United States (USA) |
| Leonhardt, Hubertus (SHS 201807 Partner + Managing Director) |
Managing Partner |
SHS Capital (Group) |
Germany |
| Leonhardt, Stefan (Kumovis 202005 Managing Director + Co-Founder) |
Managing Director |
3D Systems (Group) |
Germany |
| Leonhartsberger, Susanne (Wacker 202007–202412 Head of Biosolutions joined Wacker in 2001 LEFT 12/24) |
President/Director/Head Business Group/Unit/Division |
Wacker (Group) |
Germany |
| Leoni, Lorenzo (TiVenture Fund 201802 Managing Director + Gain Therapeutics 201802– interim CEO before Telormedix) |
Managing Director |
Fondazione Centenario BancaStato |
|
| Leppert, Angelika (Kupando 202209 CFO before Bavaria (govt) 202004 Start-up Coach, Strategy + Corporate Finance) |
Chief Financial Officer (CFO) |
Kupando GmbH |
Germany |
| Leppänen, Veli-Pekka (Nanocomp Oy 201501 CEO) |
Chief Executive Officer (CEO) |
Nanocomp Oy Ltd. |
Finland |
| Lerch, Marina (Hannover (govt) 201404 Project Director Health Care Industries) |
Cluster Manager |
Hanover (govt city) |
Germany |
| Lerch, Wolfgang (IonGate Biosciences GmbH 200709 Managing Director) |
Managing Director |
Scientific Devices Heidelberg GmbH |
Germany |
| Lerche, Dietmar (L.U.M. GmbH 201302 Managing Director) |
Managing Director |
L.U.M. GmbH (LUM GmbH) |
Germany |
| Lerchenmüller, Marc (AaviGen 202307 Managing Director + CFO + Co-Founder) |
Managing Director |
AaviGen GmbH |
Germany |
| Lernbecher, Thomas (4titude Ltd 201710 Co-Founder) |
Company Founder |
Azenta (Group) |
United Kingdom (GB) |
| Lerner, Michael (LZS-Concept GmbH 201205 Managing Director) |
Managing Director |
LZS-Concept Handels- und Service GmbH |
Austria |
| Leschly, Jake (Ingenuity 200503 CEO) |
Chief Executive Officer (CEO) |
Qiagen (Group) |
United States (USA) |
| Leschly, Nick (Bluebird Bio 201606 CEO) |
Chief Executive Officer (CEO) |
Bluebird Bio (Group) |
United States (USA) |
| Leslie, Carol (Andrew Lloyd & Associates 201509) |
public relations / investor relations |
Andrew Lloyd & Associates (ALA) |
United Kingdom (GB) |
| Lessl, Monika (Bayer 201805 Head of Corporate Innovation + RnD) |
n. a. |
Bayer (Group) |
Germany |
| Letovsky, Stan (LabCorp 201911 VP Data Sciences + Bioinformatics) |
President/Director/Head Business Group/Unit/Division |
LabCorp (Group) |
United States (USA) |
| Letzel, Thomas (Technical Univ Munich 2003– Associate Prof + Head Analytical Research Group) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
Technical University Munich (TU München, TUM) |
Germany |
| Letzelter, Susanne (Helmholtz 201401 Corporate Developm + Communication at Ascenion GmbH) |
Public Relations Manager / Investor Relations Manager |
Life Science-Stiftung (LifeScience Foundation) (Group) |
Germany |
| Leucker, Martin (Univ Lübeck 202006 Prof + Head of KI-SIGS project) |
Professor |
University of Lübeck (Universität zu Lübeck, UzL) |
Germany |
| Levensohn, Pascal (Dolby Family Ventures 201909 Managing Director + Susman Ventures 201909 Managing Director) |
Managing Director |
Dolby Family Ventures L.P. |
United States (USA) |
| Levett, Hernán (Polyphor 202001 CFO) |
Chief Financial Officer (CFO) |
Spexis (Group) |
Switzerland |
| Levick, Mark (Novartis 200807 Head Novartis Biologics) |
n. a. |
Novartis (Group) |
Switzerland |
| Levin, Johannes (Modag 201909– CMO main orgs LMU + DZNE) |
Chief Medical Officer (CMO) |
Modag GmbH |
Germany |
| Levine, Carly (AMR Action Fund 202301) |
Investment Manager |
AMR Action Fund |
|
| Levinson, Arthur D. (Genentech 200603 CEO) |
Chief Executive Officer (CEO) |
Roche (Group) |
United States (USA) |
| Levison, Derek (emp Biotech 201202 Managing Director) |
Managing Director |
emp Biotech GmbH |
Germany |
| Levitsky, Hyam (Hy) (Century Therapeutics 202010 CEO before Juno Therapeutics + Roche) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Century Therapeutics (US) |
United States (USA) |
| Levy, Frederic (Debiopharm 202003 Executive Director of Search + Evaluation + Scientific Innovation) |
n. a. |
Debiopharm (Group) |
Switzerland |
| Levy, Simon (Mahana Therapeutics 202403 CEO) |
Chief Executive Officer (CEO) |
Mahana Therapeutics (Group) |
United States (USA) |
| Lewandowska, Joanna (KCR SA 201403 PR + Marketing Manager) |
Public Relations Manager / Investor Relations Manager |
KCR CRO (Group) |
Poland |
| Lewis, Joe D. (Elara Pharmaceuticals 200911 Managing Director + Co-Founder) |
Managing Director |
Elara Pharmaceuticals GmbH |
Germany |
| Lewis, Seth (Molecular Partners 202112 before Bavarian Nordic 201703 VP Investor Relations US) |
Public Relations Manager / Investor Relations Manager |
Molecular Partners AG (SIX: MOLN, Nasdaq: MOLN) |
Switzerland |
| Lewtas, Tony (Bruker 201504 Senior Marketing Communications Manager) |
Sales Manager / Marketing Manager |
Bruker (Group) |
United States (USA) |
| Leyck Dieken, Markus (Teva 201308– Cluster Head DE + AT before InterMune Deutschland GmbH + Novartis Vaccines + Dx) |
Regional manager |
Teva (Group) |
Germany |
| Leyendecker, Ludwig (Freshfields Bruckhaus Deringer 201610) |
Attorney / Lawyer |
Freshfields (Group) |
United Kingdom (GB) |
| Li, Chen (ReLive 202301 Managing Director of Co.don GmbH) |
Chief Executive Officer (CEO) |
ReLive (Group) |
Germany |
| Li, Jason (Proteintech 202010 CEO) |
Chief Executive Officer (CEO) |
Proteintech (Group) |
United States (USA) |
| Li, Liang (Univ Alberta 201412 Professor of Chemistry) |
Professor |
University of Alberta |
Canada |
| Li, Min (SciNeuro 202303 CEO + Founder formerly GSK 201604 SVP + Global Head of Neurosciences) |
Chief Executive Officer (CEO) |
SciNeuro (Group) |
China |
| Li, Puyu (Stilla Technologies 202402– CFO before Partech (FR) + Sinovation Ventures (CN)) |
Chief Financial Officer (CFO) |
Stilla Technologies (Group) |
United States (USA) |
| Li, Yunying (B Braun 201807– General Manager of B Braun Precision Medicine Technology (Shanghai) Ltd) |
General Manager (management) |
B. Braun (Group) |
China |
| Liao, Amy (Genewiz 201809 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Azenta (Group) |
United States (USA) |
| Liapis, Anastasia (GNA Biosolutions 201803 Market Development Manager) |
Sales Manager / Marketing Manager |
GNA Biosolutions GmbH |
Germany |
| Liapounova, Elena (BioAge Labs 202412 Investor Relations) |
Public Relations Manager / Investor Relations Manager |
BioAge Labs Inc. (Nasdaq: BIOA) |
United States (USA) |
| Liautaud, Bernard (Balderton Capital 202408 Managing Partner joined 2008) |
Managing Partner (investment firm) |
Balderton Capital (UK) LLP |
United Kingdom (GB) |
| Liberati, Chiara (Golgi Neurosciences 202308 CEO before Axxam 201107 Head of Discovery) |
Researcher (industry) |
Golgi Neurosciences S.r.l. |
Italy |
| Libuda, Jennifer (Shimadzu 201404 Marketing at Shimadzu Deutschland GmbH) |
Sales Manager / Marketing Manager |
Shimadzu Deutschland GmbH |
Germany |
| Lichtenberg, Jan (InSphero 201401 CEO + Co-founder) |
Chief Executive Officer (CEO) |
InSphero (Group) |
Switzerland |
| Lichtenberger, Rainer (Atriva 201606–2023 CEO + Co-Founder before Cevec + Merckle/ratiopharm + Merck KGaA RETIRED 2023) |
Chief Executive Officer (CEO) |
Atriva Therapeutics GmbH |
Germany |
| Lichter, Peter (DKFZ 200401) |
n. a. |
Helmholtz-Gemeinschaft (HGF) (Group) |
Germany |
| Lichtfuss, Gregor (Helmholtz 201405 Project Manager Spinnovator at Ascenion) |
IP Manager |
Life Science-Stiftung (LifeScience Foundation) (Group) |
Germany |
| Lidome, Emilie (Crédit Mutuele-CIC 201806 Deputy Managing Director at CM-CIC Innovation) |
Managing Director |
Crédit Mutuel-CIC (CM-CIC) (Group) |
France |
| Liebeke, Manuel (MPI Bremen before Imperial College London) |
Researcher (university / research institute) |
Max Planck Society for the Advancement of Science |
Germany |
| Liebelt, Ute (Enzymicals 201808 Sales + Marketing) |
Sales Manager / Marketing Manager |
Enzymicals AG |
Germany |
| Liebers, Hendrik (Probiodrug 2007c–201804 CFO before IBG Sachsen-Anhalt + Sachsen LB RESIGNED 4/18) |
Chief Financial Officer (CFO) |
Vivoryon (Group) |
Germany |
| Liebig, Sören (UroTec 2010 Managing Director + founding co-owner) |
Managing Director |
MukoCell GmbH |
Germany |
| Liechtenstein, Therese Maria (Merck (DE) 202004 at M Ventures) |
Investment Manager |
Merck (DE) (Group) |
Netherlands |
| Liemen, Marcus (Accurion GmbH 201602 Managing Director) |
Managing Director |
Accurion (Group) |
Germany |
| Liersch, Oliver (Niedersachsen (govt) 200912 State Secretary Ministry of Economic Affairs, Labour and Transport) |
State Secretary |
Niedersachsen (govt region) |
Germany |
| Lies, Olaf (Niedersachsen (govt) 202302 Minister for Economic Affairs et al) |
Minister |
Niedersachsen (govt region) |
Germany |
| Liese, David (Enzymicals 202203– COO joined 2020) |
Chief Operating Officer (COO) |
Enzymicals AG |
Germany |
| Lietha, Victoria (Swisscom 202411 Investment Director at Swisscom Ventures) |
Investment Manager |
Swisscom (Group) |
Switzerland |
| Lifton, Richard P. (Roche 201503– Board Member) |
Board member, non-executive |
Roche (Group) |
Switzerland |
| Lightner, Carin (Enantios 202407 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Enantios AG |
Switzerland |
| Ligner, Emmanuel (General Electric 201812 President + CEO GE Healthcare Life Sciences) |
Chief Executive Officer (CEO) |
General Electric (Group) |
United Kingdom (GB) |
| Lilienweiss, Jakob (HTGF 202309 Investment Analyst) |
Analyst (Financial / Industry) |
High-Tech Gründerfonds (HTGF) (Group) |
Germany |
| Lilley, Patrick (Liquid Biosciences 202311 CEO) |
Chief Executive Officer (CEO) |
Liquid Biosciences (US) |
United States (USA) |
| Lillig, John (IRORI Technologies 201311– CEO before Brooks Life Science Systems + Nexus Biosystems) |
Chief Executive Officer (CEO) |
Drug Discovery Partners International |
|
| Lim, Alex (Institutional Venture Partners 202411 General Partner) |
General Partner (venture partner) |
Institutional Venture Partners (IVP) (Group) |
United Kingdom (GB) |
| Lim, Riwat (Curetis 2017Q3– Managing Director of Curetis UK Ltd + Commercial Director EMEA before Qiagen) |
Managing Director |
OpGen (Group) |
United Kingdom (GB) |
| Lim, Seung-Hak (Daniel) (Seegene 201304 Head Overseas Business division) |
President/Director/Head Business Group/Unit/Division |
Seegene (Group) |
Korea, Republic of |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo.svg){kind=logo}
1 2 3 ... 47 48 49 ... 94 95 96 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
